Mindray will exhibit more than 40 devices from its three core product segments: Patient Monitoring & Life Support products, In-vitro Diagnostic products and Medical Imaging systems. Mindray will also present demonstration units of two new products expected to be launched at the end of 2008, including the iPM, an upgraded patient monitoring device based on the current PM series of Patient Monitoring & Life Support devices, and the BS380, a 300T/H constant speed biochemistry analyzer within the In-vitro Diagnostic Products segment.
Attending the conference from Mindray will be Mr. Jie Liu, chief operating officer, Mr. Sheng Ma, vice president of international sales and Mr. Ting Yang, vice president of international marketing. Representing Mindray DS USA Inc. will be David Gibson, president, Jim Fidacaro VP of R&D and Frank Gregorio, VP of Sales. Mindray will be occupying Booth 10A37, 3F40 at the Exhibition Ground in Dusseldorf, Germany.
Mindray is a leading developer, manufacturer and marketer of medical devices worldwide. Established in 1991, Mindray offers a broad range of products across three primary business segments: patient monitoring & life support products, in-vitro diagnostic products and medical imaging systems. Mindray is globally headquartered in Shenzhen, China, with U.S. headquarters in Mahwah, New Jersey. Mindray also has another 12 international sales and service offices in Amsterdam, Frankfurt, Istanbul, London, Mexico City, Moscow, Mumbai, Paris, Sao Paolo, Seattle, Toronto and Vancouver.
For more information, please visit http://www.mindray.com .
For investor and media inquiries please contact:
In the U.S:
Evan Smith, CFA
Mindray Medical International Limited